Exact Mass: 426.13483160000004
Exact Mass Matches: 426.13483160000004
Found 500 metabolites which its exact mass value is equals to given mass value 426.13483160000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Anhydrotetracyclin
Archangelicin
Constituent of the roots of Angelica archangelica (anglica). Archangelicin is found in many foods, some of which are fats and oils, green vegetables, herbs and spices, and angelica. Archangelicin is found in angelica. Archangelicin is a constituent of the roots of Angelica archangelica (anglica)
Mometasone
Mometasone is a medium-potency synthetic corticosteroid with antiinflammatory, antipruritic, and vasoconstrictive properties. Studies in asthmatic patients have demonstrated that mometasone provides a favorable ratio of topical to systemic activity due to its primary local effect along with the extensive hepatic metabolism and the lack of active metabolites. Though effective for the treatment of asthma, glucocorticoids do not affect asthma symptoms immediately. Maximum improvement in symptoms following inhaled administration of mometasone furoate may not be achieved for 1 to 2 weeks or longer after starting treatment. he antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
fluacrypyrim
Nicarbazin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
Mangostanol
Constituent of Garcinia mangostana (mangosteen). Mangostanol is found in fruits and purple mangosteen. Mangostanol is found in fruits. Mangostanol is a constituent of Garcinia mangostana (mangosteen) Mangostanol is a natural product found in Garcinia and Garcinia mangostana with data available.
Edulisin II
Edulisin II is found in green vegetables. Edulisin II is a constituent of Angelica edulis
Mangostenol
Mangostenol is found in fruits. Mangostenol is a constituent of the green fruit hulls of Garcinia mangostana (mangosteen).
6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside
C20H26O10 (426.15258960000006)
6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside is found in herbs and spices. 6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside is a constituent of fennel, Foeniculum vulgare. Constituent of fennel, Foeniculum vulgare. 6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside is found in herbs and spices.
Atrovirisidone
Atrovirisidone is found in fruits. Atrovirisidone is a constituent of the roots of Garcinia atroviridis (gelugor). Constituent of the roots of Garcinia atroviridis (gelugor). Atrovirisidone is found in fruits.
Chitobiose
Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated. [HMDB] Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated.
Butanoic acid, 3-((2-naphthalenylsulfonyl)amino)-4-oxo-4-((2-phenylethyl)amino)-, (S)-
C22H22N2O5S (426.12493620000004)
Antibiotic M83
D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins
Descarboxyethoxyloratadine
C24H27ClN2O3 (426.17101020000007)
Garenoxacin
C23H20F2N2O4 (426.13910640000006)
Lenvatinib
C21H19ClN4O4 (426.10947640000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Praeruptorin B
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2-(1H-imidazol-1-ylmethyl)-6-methyl-4-(3-nitrophenyl)-, 3-ethyl 5-methyl ester
Vericiguat
C19H16F2N8O2 (426.1364219999999)
Yadanziolide A
C20H26O10 (426.15258960000006)
yadanziolide A is a natural product found in Brucea javanica and Brucea mollis with data available. Yadanziolide A, isolated from the cultivated dry seeds of Brucea javanica, has strong antiviral activities with IC50 of 5.5 μM against tobacco mosaic virus. Yadanziolide A shows significant antitumor effects[1][2]. Yadanziolide A, isolated from the cultivated dry seeds of Brucea javanica, has strong antiviral activities with IC50 of 5.5 μM against tobacco mosaic virus. Yadanziolide A shows significant antitumor effects[1][2].
anomalin
(-)-Praeruptorin B is a natural product found in Angelica cartilaginomarginata, Angelica anomala, and other organisms with data available. Praeruptorin B is a natural product found in Saposhnikovia divaricata with data available. (-)-Anomalin ((-)-Praeruptorin B) is a coumarin derivative isolated from the root of Angelica anomala[1]. (-)-Anomalin ((-)-Praeruptorin B) is a coumarin derivative isolated from the root of Angelica anomala[1]. (-)-Anomalin ((-)-Praeruptorin B) is a coumarin derivative isolated from the root of Angelica anomala[1]. (-)-Anomalin ((-)-Praeruptorin B) is a coumarin derivative isolated from the root of Angelica anomala[1]. Praeruptorin B is an inhibitor of sterol regulatory element-binding proteins (SREBPs). Praeruptorin B is an inhibitor of sterol regulatory element-binding proteins (SREBPs). Praeruptorin B is an inhibitor of sterol regulatory element-binding proteins (SREBPs).
Villosinol
Villosin
2-(1-Hydroxy-1-methylethyl)-4,8-dihydroxy-6-(3-methyl-2-butenyl)-7-methoxy-2,3-dihydro-5H-furo[3,2-b]xanthene-5-one
11-Hydroxytephrosin
Ponganone VIII
8-Deoxy-15-(3-hydroxy-2-methyl-propanoyl)-lactucin-3-sulfate
5-Hydroxy-8-(4-hydroxy-3,5-dimethoxyphenyl)-10-methoxy-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b]dipyran-6-one
5-Hydroxy-3,8-dimethoxy-3,4-methylenedioxy-7-prenyloxyflavone
BML-190
C23H23ClN2O4 (426.13462680000004)
N-Fructosyl gamma-glutamyl-S-methylcysteine
Annotation level-3
calypteryxin|Peuformosin|Peuformosin; 3-Angeloyloxy-4-senecioyloxy-3,4-dihydro-seselin
(-)-spicigerolide|(1S,2S,3Z)-2-(acetyloxy)-1-[(1S,2S)-1,2-di(acetyloxy)propyl]-4-[(2R)-6-oxo-3,6-dihydro-2H-2-pyranyl]-3-butenyl acetate|(6R)-6-[(1Z,3S,4S,5S,6S)-(3,4,5,6-tetraacetoxyhept-1-enyl)]-5,6-dihydropyran-2-one|6R-[3S,4S.5S,6S-tetraacetyloxy-1Z-heptenyl]-5,6-dihydro-2H-pyran-2-one|spicigerolide
C20H26O10 (426.15258960000006)
2-hydroxy-3,4,45-tetramethoxy-5,6-(2,2-dimethylpyrano)chalcone
11beta,13-dihydrolactucin-8-O-p-methoxyphenylacetate|11betaH,13-dihydrolactucin-8-O-p-methoxyphenylacetate
2-O-beta-D-Glucopyranoside-(R)-Peucedanol
C20H26O10 (426.15258960000006)
N,2,3,5-Tetra-Ac-beta-D-5-Amino-1-ribofuranosyl-1H-imidazole-4-carboxamide
2-acetyl-1,3-dicoumaroylglycerol|2-acetyl-1,3-di[(E)-p-coumaroyl]glycerol|Lasiocarpin A
O-(6-O-Caffeoyl-beta-D-glucopyranoside)-(S)-4-Hydroxy-2-pentanone
C20H26O10 (426.15258960000006)
(1R,2S,3R,4S)-1-Ac,1,3-debenzoyl-5-(Hydroxymethyl)-5-cyclohexene-1,2,3,4-tetrol|acetyl piperenol A
(6aS)-3-[(1S*,2S*,4R*)-4-hydroxy-2-methyl-6-oxocyclohexyl]-6aH-furo[2,3-h]isochromene-6,8-dione|multiformin D
4-angeloyloxy-3-senecioyloxy-(-)-trans-khellactone
uvarirufol B|{(1R,4S,5R,6S)-6-acetoxy-1,4-dihydroxy-5-[(benzoyl)oxy]cyclohex-2-en-1-yl}methyl benzoate
9alpha,11-dihydroxy-13-chloro-11,13-dihydroatripliciolide-8-O-angelate
(1R,2R,5R,6S,E)-1-((R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)hept-3-ene-1,2,5,6-tetryl tetraacetate|6R-<1R,2R,5R,6S-(tetraacetyloxy)-3E-heptenyl>-5,6-dihydro-2H-pyran-2-one|6R-[1R,2R,5R,6S-(tetraacetyloxy)-3E-heptenyl]-5,6-dihydro-2H-pyran-2-one|6R-[1S,2R,5R,6S-(tetraacetyloxy)-3E-heptenyl]-5,6-dihydro-2H-pyran-2-one
C20H26O10 (426.15258960000006)
1,3,6-trihydroxy-8-(7-hydroxy-3,7-dimethyl-2,5-octadieyl)-7-methoxyxanthone
4-O-(4-hydroxyprenyl)-caffeic acid 4-O-beta-D-glucopyranoside|4-O-<4-hydroxyprenyl>-caffeic acid 4-O-beta-D-glucopyranoside
C20H26O10 (426.15258960000006)
(-)-6-acetylzeylenol|(-)-6-O-acetyl-1-benzoyloxymethylcyclohex-4-en-1,2,3,6-tetrol
1,4-dihydroxy-3-[4-hydroxyphenyl-(4-hydroxy-3-methoxybenzyl)]-2-(3,5-dihydroxyphenyl)butane|pouzolignan B
(2R,3S)-6-acetyl-2-[1-O-(beta-D-glucopyranosyl)-2-propenyl]-5-hydroxy-3-methoxy-2,3-dihydrobenzofuran
C20H26O10 (426.15258960000006)
(5E,8Z,14Z)-6-iodoicosa-5,8,14,19-tetraen-11-ynoic acid
2-(3,4-Dimethoxyphenyl)-3,5-dimethoxy-7-(prenyloxy)-4H-1-benzopyran-4-one
2-(1,3-Benzodioxole-5-yl)-3,5-dimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
5-O-beta-D-glucopyranosyl-1,3,8-trihydroxy-5,6,7,8-tetrahydroxanthone
C19H22O11 (426.11620619999997)
(2S)-3-methyl-3-butene-1,2-diol 1-O-(6-caffeoyl)-beta-D-glucopyranoside|rotundarpenoside A
C20H26O10 (426.15258960000006)
4-caffeoyl-3-methyl-but-2-ene-1,4-diol 1-O-beta-D-glucopyranoside|rotundarpenoside B
C20H26O10 (426.15258960000006)
(-)-deguoic acid|5-(6,7-dimethoxy-2,3-dihydrochromon-3-oxy) beta-tubaic acid
2-Hexanoyl-1,3,6,8-tetramethoxy-9,10-anthraquinone
(-)-rotoic acid|4-(2,3-dihydro-6,7-dimethoxychromon-3-oxy) tubaic acid
4(S)-(6-O-Caffeoyl-beta-D-glucopyranosyl)-2-pentanone
C20H26O10 (426.15258960000006)
1-oxo-6beta-cinnamoyloxy-1,10-dihydro-secomacrotolide
3-O-beta-D-glucopyranosyl khellactone
C20H26O10 (426.15258960000006)
19-Ac-(ent-4beta,7alpha,12betaH)-18-Chloro-15,16-epoxy-4,7,19-trihyrdroxy-3,6-dioxo-13(16),14-clerodadien-20,12-olide
(-)-8-[(2S),3-dihydroxy-3-methylbutyl]-7-hydroxychromen-2-one 7-O-beta-D-glucopyranoside|devenyoside B
C20H26O10 (426.15258960000006)
1,3,6-trihydroxy-8-(6,7-epoxy-3,7-dimethyl-2-octenyl)-7-methoxyxanthone
1,3,6-Trihydroxy-2-(2-hydroxy-3-methyl-3-butenyl)-5-methoxy-7-(3-methyl-2-butenyl)xanthone
N-[4-(4-Hydroxybenzoylamino)butyl]-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxopteridine-6-carboxamide
(+)-tephrorin A|(2S)-8-[(2S,3R,4S)-4-(acetyloxy)tetrahydro-2-hydroxy-5,5-dimethyl-3-furanyl]-2,3-dihydro-7-methoxy-2-phenyl-4H-1-benzopyran-4-one
3,4,7,8-tetrmethoxy-5,6-(2,2-dimethylpyrano)flavone
Fmoc-Trp-OH
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.268 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.264
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate
C20H26O10_2-(beta-D-Glucopyranosyloxy)benzyl 1,6-dihydroxy-2-cyclohexene-1-carboxylate
C20H26O10 (426.15258960000006)
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate
N-desmethylclindamycin sulfoxide
C17H31ClN2O6S (426.15912560000004)
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate [IIN-based: Match]
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate [IIN-based on: CCMSLIB00000846416]
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate [IIN-based on: CCMSLIB00000845537]
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate [IIN-based on: CCMSLIB00000845540]
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate [IIN-based: Match]
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate_major
[8,8-dimethyl-9-(3-methylbut-2-enoyloxy)-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] 3-methylbut-2-enoate_98.9\\%
Ala Ala Cys Tyr
C18H26N4O6S (426.15729760000005)
Ala Ala Tyr Cys
C18H26N4O6S (426.15729760000005)
Ala Cys Ala Tyr
C18H26N4O6S (426.15729760000005)
Ala Cys Cys Met
Ala Cys Phe Ser
C18H26N4O6S (426.15729760000005)
Ala Cys His Pro
C17H26N6O5S (426.16853060000005)
Ala Cys Met Cys
Ala Cys Pro His
C17H26N6O5S (426.16853060000005)
Ala Cys Ser Phe
C18H26N4O6S (426.15729760000005)
Ala Cys Tyr Ala
C18H26N4O6S (426.15729760000005)
Ala Phe Cys Ser
C18H26N4O6S (426.15729760000005)
Ala Phe Ser Cys
C18H26N4O6S (426.15729760000005)
Ala His Cys Pro
C17H26N6O5S (426.16853060000005)
Ala His Pro Cys
C17H26N6O5S (426.16853060000005)
Ala Met Cys Cys
Ala Pro Cys His
C17H26N6O5S (426.16853060000005)
Ala Pro His Cys
C17H26N6O5S (426.16853060000005)
Ala Ser Cys Phe
C18H26N4O6S (426.15729760000005)
Ala Ser Phe Cys
C18H26N4O6S (426.15729760000005)
Ala Tyr Ala Cys
C18H26N4O6S (426.15729760000005)
Ala Tyr Cys Ala
C18H26N4O6S (426.15729760000005)
Cys Ala Ala Tyr
C18H26N4O6S (426.15729760000005)
Cys Ala Cys Met
Cys Ala Phe Ser
C18H26N4O6S (426.15729760000005)
Cys Ala His Pro
C17H26N6O5S (426.16853060000005)
Cys Ala Met Cys
Cys Ala Pro His
C17H26N6O5S (426.16853060000005)
Cys Ala Ser Phe
C18H26N4O6S (426.15729760000005)
Cys Ala Tyr Ala
C18H26N4O6S (426.15729760000005)
Cys Cys Ala Met
Cys Cys Cys Val
Cys Cys Met Ala
Cys Cys Thr Thr
C14H26N4O7S2 (426.12428459999995)
Cys Cys Val Cys
Cys Phe Ala Ser
C18H26N4O6S (426.15729760000005)
Cys Phe Gly Thr
C18H26N4O6S (426.15729760000005)
Cys Phe Ser Ala
C18H26N4O6S (426.15729760000005)
Cys Phe Thr Gly
C18H26N4O6S (426.15729760000005)
Cys Gly Phe Thr
C18H26N4O6S (426.15729760000005)
Cys Gly Thr Phe
C18H26N4O6S (426.15729760000005)
Cys His Ala Pro
C17H26N6O5S (426.16853060000005)
Cys His Pro Ala
C17H26N6O5S (426.16853060000005)
Cys Met Ala Cys
Cys Met Cys Ala
Cys Met Ser Ser
C14H26N4O7S2 (426.12428459999995)
Cys Pro Ala His
C17H26N6O5S (426.16853060000005)
Cys Pro His Ala
C17H26N6O5S (426.16853060000005)
Cys Ser Ala Phe
C18H26N4O6S (426.15729760000005)
Cys Ser Phe Ala
C18H26N4O6S (426.15729760000005)
Cys Ser Met Ser
C14H26N4O7S2 (426.12428459999995)
Cys Ser Ser Met
C14H26N4O7S2 (426.12428459999995)
Cys Thr Cys Thr
C14H26N4O7S2 (426.12428459999995)
Cys Thr Phe Gly
C18H26N4O6S (426.15729760000005)
Cys Thr Gly Phe
C18H26N4O6S (426.15729760000005)
Cys Thr Thr Cys
C14H26N4O7S2 (426.12428459999995)
Cys Val Cys Cys
Cys Tyr Ala Ala
C18H26N4O6S (426.15729760000005)
Phe Ala Cys Ser
C18H26N4O6S (426.15729760000005)
Phe Ala Ser Cys
C18H26N4O6S (426.15729760000005)
Phe Cys Ala Ser
C18H26N4O6S (426.15729760000005)
Phe Cys Gly Thr
C18H26N4O6S (426.15729760000005)
Phe Cys Ser Ala
C18H26N4O6S (426.15729760000005)
Phe Cys Thr Gly
C18H26N4O6S (426.15729760000005)
Phe Gly Cys Thr
C18H26N4O6S (426.15729760000005)
Phe Gly Thr Cys
C18H26N4O6S (426.15729760000005)
Phe Ser Ala Cys
C18H26N4O6S (426.15729760000005)
Phe Ser Cys Ala
C18H26N4O6S (426.15729760000005)
Phe Thr Cys Gly
C18H26N4O6S (426.15729760000005)
Phe Thr Gly Cys
C18H26N4O6S (426.15729760000005)
Gly Cys Phe Thr
C18H26N4O6S (426.15729760000005)
Gly Cys Thr Phe
C18H26N4O6S (426.15729760000005)
Gly Phe Cys Thr
C18H26N4O6S (426.15729760000005)
Gly Phe Thr Cys
C18H26N4O6S (426.15729760000005)
Gly Gly Met Tyr
C18H26N4O6S (426.15729760000005)
Gly Gly Tyr Met
C18H26N4O6S (426.15729760000005)
Gly Met Gly Tyr
C18H26N4O6S (426.15729760000005)
Gly Met Tyr Gly
C18H26N4O6S (426.15729760000005)
Gly Thr Cys Phe
C18H26N4O6S (426.15729760000005)
Gly Thr Phe Cys
C18H26N4O6S (426.15729760000005)
Gly Tyr Gly Met
C18H26N4O6S (426.15729760000005)
Gly Tyr Met Gly
C18H26N4O6S (426.15729760000005)
His Ala Cys Pro
C17H26N6O5S (426.16853060000005)
His Ala Pro Cys
C17H26N6O5S (426.16853060000005)
His Cys Ala Pro
C17H26N6O5S (426.16853060000005)
His Cys Pro Ala
C17H26N6O5S (426.16853060000005)
His Pro Ala Cys
C17H26N6O5S (426.16853060000005)
His Pro Cys Ala
C17H26N6O5S (426.16853060000005)
Met Ala Cys Cys
Met Cys Ala Cys
Met Cys Cys Ala
Met Cys Ser Ser
C14H26N4O7S2 (426.12428459999995)
Met Gly Gly Tyr
C18H26N4O6S (426.15729760000005)
Met Gly Tyr Gly
C18H26N4O6S (426.15729760000005)
Met Ser Cys Ser
C14H26N4O7S2 (426.12428459999995)
Met Ser Ser Cys
C14H26N4O7S2 (426.12428459999995)
Met Tyr Gly Gly
C18H26N4O6S (426.15729760000005)
Pro Ala Cys His
C17H26N6O5S (426.16853060000005)
Pro Ala His Cys
C17H26N6O5S (426.16853060000005)
Pro Cys Ala His
C17H26N6O5S (426.16853060000005)
Pro Cys His Ala
C17H26N6O5S (426.16853060000005)
Pro His Ala Cys
C17H26N6O5S (426.16853060000005)
Pro His Cys Ala
C17H26N6O5S (426.16853060000005)
Ser Ala Cys Phe
C18H26N4O6S (426.15729760000005)
Ser Ala Phe Cys
C18H26N4O6S (426.15729760000005)
Ser Cys Ala Phe
C18H26N4O6S (426.15729760000005)
Ser Cys Phe Ala
C18H26N4O6S (426.15729760000005)
Ser Cys Met Ser
C14H26N4O7S2 (426.12428459999995)
Ser Cys Ser Met
C14H26N4O7S2 (426.12428459999995)
Ser Phe Ala Cys
C18H26N4O6S (426.15729760000005)
Ser Phe Cys Ala
C18H26N4O6S (426.15729760000005)
Ser Met Cys Ser
C14H26N4O7S2 (426.12428459999995)
Ser Met Ser Cys
C14H26N4O7S2 (426.12428459999995)
Ser Ser Cys Met
C14H26N4O7S2 (426.12428459999995)
Ser Ser Met Cys
C14H26N4O7S2 (426.12428459999995)
Thr Cys Cys Thr
C14H26N4O7S2 (426.12428459999995)
Thr Cys Phe Gly
C18H26N4O6S (426.15729760000005)
Thr Cys Gly Phe
C18H26N4O6S (426.15729760000005)
Thr Cys Thr Cys
C14H26N4O7S2 (426.12428459999995)
Thr Phe Cys Gly
C18H26N4O6S (426.15729760000005)
Thr Phe Gly Cys
C18H26N4O6S (426.15729760000005)
Thr Gly Cys Phe
C18H26N4O6S (426.15729760000005)
Thr Gly Phe Cys
C18H26N4O6S (426.15729760000005)
Thr Thr Cys Cys
C14H26N4O7S2 (426.12428459999995)
Val Cys Cys Cys
Tyr Ala Ala Cys
C18H26N4O6S (426.15729760000005)
Tyr Ala Cys Ala
C18H26N4O6S (426.15729760000005)
Tyr Cys Ala Ala
C18H26N4O6S (426.15729760000005)
Tyr Gly Gly Met
C18H26N4O6S (426.15729760000005)
Tyr Gly Met Gly
C18H26N4O6S (426.15729760000005)
Tyr Met Gly Gly
C18H26N4O6S (426.15729760000005)
(+)-Tephrorin A
A monomethoxyflavanone that is (2S)-7-methoxyflavanone substituted at position 8 by a tetrahydrofuran ring which in turn is substituted by geminal methyl groups at position 2, an acetoxy group at position 3 and a hydroxy group at position 5. Isolated from Tephrosia purpurea, it exhibits antineoplastic activity.
Anhydrotetracycline
Asn-Trp-OH
C20H18N4O7 (426.11754379999996)
mangostanol
Edulisin II
6-(2-Carboxyethyl)-7-hydroxy-2,2-dimethyl-4-chromanone glucoside
C20H26O10 (426.15258960000006)
Atrovirisidone
Mangostenol
2,2-(5-Bromo-2-fluoro-1,3-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
Hexyl(triphenyl)phosphonium bromide
C24H28BrP (426.11118780000004)
Cetotiamine
C18H26N4O6S (426.15729760000005)
(3-ETHOXYCARBONYL-2-OXOPROPLY)TRIPHENYLPHOSPHONIUM CHLORIDE
Fenbenicillin
C22H22N2O5S (426.12493620000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
2-benzofuran-1,3-dione,2,2-dimethylpropane-1,3-diol,furan-2,5-dione,propane-1,2-diol
C20H26O10 (426.15258960000006)
3-QUINOLINAMINE, N-[2-(3,4,5-TRIMETHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-
N-(phenylsulphonyl)anthranilic acid, compound with 2,2,2-nitrilotriethanol (1:1)
C19H26N2O7S (426.14606460000005)
Garenoxacin
C23H20F2N2O4 (426.13910640000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
2-(4-methoxyphenyl)-4,6-diphenylpyrylium tetrafluoroborate
1,3-diisocyanato-2-methylbenzene,hexanedioic acid,2-(2-hydroxyethoxy)ethanol
2,4-DIFLUORO-N-(2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)BENZENESULFONAMIDE
C18H21BF2N2O5S (426.12322300000005)
U0126-EtOH
U0126 (U0126-EtOH) is a potent, non-ATP competitive and selective MEK1 and MEK2 inhibitor, with IC50s of 72 nM and 58 nM, respectively. U0126 is an autophagy and mitophagy inhibitor[1][2][3][4].
1,5-DI-O-(4-METHYLBENZOYL)-2,3-O-ISOPROPYLIDENE-BETA-D-RIBOFURANOSE
Benzenamine,4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-2-methyl-,hydrochloride (1:1)
(1S)-1,5-Anhydro-1-{4-methyl-3-[(5-phenyl-2-thienyl)methyl]phenyl}-D-glucitol
C24H26O5S (426.15008660000007)
p-Nitrophenyl 2-Acetamido-2-deoxy-3,6-di-O-acetyl-β-D-glucopyranoside
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
(S,S)-1,2-Bis[(o-tolyl)(phenylphosphino)]ethane,(S,S)-1,2-Ethanediylbis[(2-methylphenyl)phenylphosphine]
.beta.-D-Glucopyranosiduronic acid, phenyl 1-thio-, methyl ester, triacetate
ICI 199,441 hydrochloride
ICI 199441 is a potent and selective κ-opioid receptor agonist. ICI 199441 can improve heart resistance to ischemia/reperfusion[1].
Pregna-1,4-diene-3,20-dione,9,11-dichloro-17,21-dihydroxy-16-methyl-, (11b,16a)-
4-Epianhydrotetracycline
4-Epianhydrotetracycline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=7518-17-4 (retrieved 2024-10-30) (CAS RN: 7518-17-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
N-(1-(2,2-DIFLUORO-2-(4-(TRIFLUOROMETHYL)PHENYL)ETHYL)PIPERIDIN-4-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
Vericiguat
C19H16F2N8O2 (426.1364219999999)
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
C23H20F2N2O4 (426.13910640000006)
N-[2-[2-(3-methoxyphenoxy)anilino]-2-oxoethyl]naphthalene-1-carboxamide
N-[(5-imino-3-methyl-1-phenyl-4-pyrazolylidene)amino]-3-(4-morpholinylsulfonyl)aniline
2-[[3-(3,4-dimethoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]thio]-N-(5-methyl-3-isoxazolyl)acetamide
C19H18N6O4S (426.11101880000007)
2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-3-(1H-indol-3-yl)propanoic acid
1-[3-({[(4-Amino-5-fluoro-2-methylquinolin-3-YL)methyl]thio}methyl)phenyl]-2,2,2-trifluoroethane-1,1-diol
N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan
C22H22N2O5S (426.12493620000004)
(4AR,6R,7S,8R,8AR)-8-((5R,6R)-3-Carboxy-tetrahydro-4,5,6-trihydroxy-2H-pyran-2-yloxy)-hexahydro-6,7-dihydroxy-2-methylpyrano[3,2-D][1,3]dioxine-2-carboxylic acid)
Lenvatinib
C21H19ClN4O4 (426.10947640000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
4,18-Dihydroxy-15-(3-hydroxy-3-methylbutyl)-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
(1S,4aS,12aS)-3-carbamoyl-1-(dimethylammonio)-4a,6,7-trihydroxy-11-methyl-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate
1,3,6-trihydroxy-2-[(2R)-2-hydroxy-3-methylbut-3-enyl]-7-methoxy-8-(3-methylbut-2-enyl)xanthen-9-one
3-(2-fluorophenyl)-6-[4-methoxy-3-(3-oxolanyloxy)phenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
Prasterone
C19H31NaO7S (426.16880960000003)
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
(E)-N-[[4-(morpholin-4-ylmethyl)phenyl]carbamothioyl]-3-(3-nitrophenyl)prop-2-enamide
C21H22N4O4S (426.13616920000004)
3-[[2-[4-(3-chlorophenyl)-1-piperazinyl]-1-oxoethyl]amino]-1H-indole-2-carboxylic acid methyl ester
C22H23ClN4O3 (426.14585980000004)
3-[[2-[[4-Ethyl-5-[(3-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid
C21H22N4O4S (426.13616920000004)
2-[[5-(4-fluorophenyl)-1-methyl-2-imidazolyl]thio]-N-[2-(4-morpholinyl)phenyl]acetamide
2-[[2-[(3,7-Dimethyl-2-quinolinyl)thio]-1-oxoethyl]amino]-4,5-dimethoxybenzoic acid
C22H22N2O5S (426.12493620000004)
N-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
C22H22N2O5S (426.12493620000004)
S-butyryl-4-phosphopantetheine(2-)
C15H27N2O8PS-2 (426.12256720000005)
N-[3-(1-azepanylsulfonyl)phenyl]-4-oxo-1-benzopyran-2-carboxamide
C22H22N2O5S (426.12493620000004)
2-(4-oxo-3-quinazolinyl)-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide
C21H22N4O4S (426.13616920000004)
[(9R)-8-[2-[(Z)-2-Methylbut-2-enoyl]oxypropan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate
2-[4-(5-{[(2-Methylphenyl)sulfonyl]methyl}-2-furoyl)piperazin-1-yl]pyrimidine
C21H22N4O4S (426.13616920000004)
1-(2-Fluorophenyl)-5-[[4-(4-morpholinyl)anilino]methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione
ethyl (2Z)-2-[(5Z)-3-[2-(furan-2-ylmethylamino)-2-oxoethyl]-5-[(4-methylphenyl)methylidene]-4-oxo-1,3-thiazolidin-2-ylidene]acetate
C22H22N2O5S (426.12493620000004)
[1-methyl-1-[(9R)-9-(3-methylbut-2-enoyloxy)-2-oxo-8,9-dihydrofuro[2,3-h]chromen-8-yl]ethyl] (E)-2-methylbut-2-enoate
N-cyclohexyl-2-[(2R,3S,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-cyclohexyl-2-[(2S,3S,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-cyclohexyl-2-[(2S,3R,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-cyclohexyl-2-[(2R,3R,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-cyclohexyl-2-[(2S,3S,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
[(1R,2aR,8bR)-2-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-oxanyl)methanone
C24H27ClN2O3 (426.17101020000007)
N-cyclohexyl-2-[(2S,3R,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-cyclohexyl-2-[(2R,3S,6R)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-cyclohexyl-2-[(2R,3R,6S)-3-[(4-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
C20H27FN2O5S (426.16246240000004)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]methanesulfonamide
C19H26N2O7S (426.14606460000005)
[(1S,2aR,8bR)-2-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-oxanyl)methanone
C24H27ClN2O3 (426.17101020000007)
[(1S,2aS,8bS)-2-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-oxanyl)methanone
C24H27ClN2O3 (426.17101020000007)
[(1R,2aS,8bS)-2-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(4-oxanyl)methanone
C24H27ClN2O3 (426.17101020000007)
(1R,5S)-7-[4-(2-fluorophenyl)phenyl]-6-(3-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptane
C23H20F2N2O2S (426.12134840000004)
3,4,5-Trihydroxy-6-[2-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]propanoyl]oxyoxane-2-carboxylic acid
C20H26O10 (426.15258960000006)
6-[3-(1,2-Dihydroxybutyl)-1-oxoisochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
C19H22O11 (426.11620619999997)
15-(1,3-Dihydroxy-3-methylbutyl)-18-hydroxy-2-methoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
1,3,5-Benzenetricarboxylic acid tri(trimethylsilyl) ester
13,21-Dihydroxy-16,17-dimethoxy-6-prop-1-en-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one
2-(4-(4-Nitrophenyl)-6-phenyl-2-pyrimidinylamino)benzoic acid methyl ester
1,2,3-Benzenetricarboxylic acid tri(trimethylsilyl) ester
4,7-DI(Para-methoxyphenyl)-6-(pyridin-4-YL)-1,2,5-thiadiazolo(3,4-C)pyridine
[8-[2-(3-methylbut-2-enoyloxy)propan-2-yl]-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate
Mometasone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07X - Corticosteroids, other combinations > D07XC - Corticosteroids, potent, other combinations R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents
anhydrotetracycline zwitterion
Zwitterionic form of anhydrotetracycline arising from transfer of a proton from the 2-hydroxy to the tertiary amino group; major species at pH 7.3.
Archangelicin
S-butyryl-4-phosphopantetheine(2-)
C15H27N2O8PS (426.12256720000005)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-butyryl-4-phosphopantetheine; major species at pH 7.3.
(2r,3s)-3-[(1s,14s,15r)-11-hydroxy-4,12,14,15-tetramethyl-3,6-dioxo-8,16-dioxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-2(7),4,9(17),10,12-pentaen-5-yl]butan-2-yl formate
1,3,6-trihydroxy-2-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-5-methoxy-7-(3-methylbut-2-en-1-yl)xanthen-9-one
3-(4-hydroxy-2-methyl-6-oxocyclohexyl)-6a-methyl-9-(2-methylbutanoyl)furo[2,3-h]isochromene-6,8-dione
6-(2,3-dihydroxy-3-methylbutyl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
C20H26O10 (426.15258960000006)
2,5-bis(acetyloxy)-7-[3-(acetyloxy)-6-oxo-2,3-dihydropyran-2-yl]hept-6-en-3-yl acetate
C20H26O10 (426.15258960000006)
(1r,4s,5r,6s)-6-(acetyloxy)-5-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
5-hydroxy-4-(7-methoxy-4-oxo-2-phenyl-2,3-dihydro-1-benzopyran-8-yl)-2,2-dimethyloxolan-3-yl acetate
(9s,10s)-8,8-dimethyl-10-{[(2z)-2-methylbut-2-enoyl]oxy}-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl (2z)-2-methylbut-2-enoate
2-[(1r,2r)-1,2-dihydroxypropyl]-7-methoxy-5-methyl-8-[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
C20H26O10 (426.15258960000006)
8,8-dimethyl-10-[(2-methylbut-2-enoyl)oxy]-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl 3-methylbut-2-enoate
6-(acetyloxy)-2-[(benzoyloxy)methyl]-4,5-dihydroxycyclohex-2-en-1-yl benzoate
5-(2-hydroxy-1-methanesulfonylpropan-2-yl)-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
C20H26O8S (426.13483160000004)
(1r,14r)-11,14-dihydroxy-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-3,5,9,11,15(20),16,18-heptaen-13-one
3-(2-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}propyl)-8-hydroxy-6-methoxyisochromen-1-one
C20H26O10 (426.15258960000006)
(3s)-3-ethyl-7-hydroxy-3,6-dimethyl-1-oxo-2-benzofuran-5-yl 6-[(2e)-but-2-en-2-yl]-2,4-dihydroxy-3-methylbenzoate
6-[(6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl)methyl]-5-hydroxy-7-methoxy-2-methylchromen-4-one
6-{[(3r)-6,8-dihydroxy-3,7-dimethyl-1-oxo-3,4-dihydro-2-benzopyran-5-yl]methyl}-5-hydroxy-7-methoxy-2-methylchromen-4-one
3,6-bis(acetyloxy)-1-[3-(acetyloxy)-6-oxo-2,3-dihydropyran-2-yl]hept-1-en-4-yl acetate
C20H26O10 (426.15258960000006)
3,6,8-trihydroxy-2-methoxy-1-({1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl}methyl)xanthen-9-one
9-(hydroxymethyl)-3,6-dimethyl-2,7-dioxo-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-(4-methoxyphenyl)acetate
1-[(2r,3s)-5-hydroxy-3-methoxy-2-(3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-6-yl]ethanone
C20H26O10 (426.15258960000006)
6-[(2s)-2,3-dihydroxy-3-methylbutyl]-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
C20H26O10 (426.15258960000006)
2,3,12,15,16-pentahydroxy-17-(hydroxymethyl)-9,13-dimethyl-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-ene-4,11-dione
C20H26O10 (426.15258960000006)
(1r,2r,3r,6s,7r,8s,12s,13s,14r,15r,16s,17r)-2,3,7,12,15,16-hexahydroxy-9,13,17-trimethyl-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-ene-4,11-dione
C20H26O10 (426.15258960000006)
2-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-3,8-dimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
3-{3-hydroxy-4-[(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl)oxy]phenyl}prop-2-enoic acid
C20H26O10 (426.15258960000006)
7-hydroxy-6-(2-hydroxy-3-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)chromen-2-one
C20H26O10 (426.15258960000006)
(2r,2's,4s,6s,7s,10s,12s)-2',12,17-trihydroxy-6-methyl-3,8-dioxaspiro[hexacyclo[11.8.0.0²,⁴.0²,¹⁰.0⁶,¹⁰.0¹⁴,¹⁹]henicosane-7,3'-oxolane]-1(13),14,16,18-tetraene-5',20-dione
2-[(1r,2s)-1,2-dihydroxypropyl]-7-methoxy-5-methyl-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
C20H26O10 (426.15258960000006)
(3s)-3,5,9-trihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-3,4-dihydro-1,11-dioxatetracen-6-one
1,3,6-trihydroxy-2-(4-hydroxy-3-methylbut-2-en-1-yl)-7-methoxy-8-(3-methylbut-2-en-1-yl)xanthen-9-one
10-{[2-(4-hydroxyphenyl)ethyl]amino}-5,11-dimethoxy-16-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one
3-[(2s)-2-{[(2r,3s,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}propyl]-8-hydroxy-6-methoxyisochromen-1-one
C20H26O10 (426.15258960000006)
7-hydroxy-8-[(2r)-2-hydroxy-3-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]chromen-2-one
C20H26O10 (426.15258960000006)